drugset / Trial / NCT05251259
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomised, placebo-controlled, double-blind study to assess the efficacy and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma.
Timeline
- Start
- 2022-01-27
- Primary completion
- 2026-01-07
- Completion
- 2026-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atuliflapon | Small molecule | — | Oral |